Search

Your search keyword '"Guigay, Joël"' showing total 25 results
Start Over Author "Guigay, Joël" Publisher american association for cancer research (aacr)
25 results on '"Guigay, Joël"'

1. Supplementary Table 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

2. Supplementary Table 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table 5 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 5 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 4 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 7 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table 6 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 4 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table 6 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table 7 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

21. Abstract 1237: Randomized phase II trial of pre-operative afatinib in non-metastatic head and neck squamous cell carcinoma patients: Identification of predictive biomarkers of response

Author

Marret, Grégoire, primary, Kamal, Maud, additional, Gal, Jocelyn, additional, Temam, Stéphane, additional, Klijianenko, Jerzy, additional, Delord, Jean-Pierre, additional, Hoffmann, Caroline, additional, Dolivet, Gilles, additional, Malard, Olivier, additional, Fayette, Jerôme, additional, Capitain, Olivier, additional, Even, Caroline, additional, Vergez, Sébastien, additional, Geoffrois, Lionel, additional, Rolland, Frédéric, additional, Zrounba, Philippe, additional, Laccourreye, Laurent, additional, Guigay, Joël, additional, Aide, Nicolas, additional, Bénavent, Valérie, additional, Lamy, Constance, additional, Girard, Elodie, additional, Jimenez, Marta, additional, Bièche, Ivan, additional, and Tourneau, Christophe Le, additional

Published
2022
Full Text
View/download PDF

22. Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, additional, Li, Shau-Hsuan, additional, Ngan, Roger K-C, additional, Dechaphunkul, Arunee, additional, Zhang, Li, additional, Yen, Chia-Jui, additional, Chan, Po Chung, additional, Chakrabandhu, Somvilai, additional, Ma, Brigette B.Y., additional, Tanasanvimon, Suebpong, additional, Lee, Victor H.F., additional, Lou, Pei-Jen, additional, Li, Zujun, additional, Spira, Alexander I., additional, Sukari, Ammar, additional, Guigay, Joël, additional, McCune, Steven, additional, Gonzalez-Maffe, Juan, additional, Szpakowski, Sebastian, additional, Yao, Yao, additional, Liang, Hongzi, additional, Mataraza, Jennifer, additional, Séchaud, Romain, additional, Manenti, Luigi, additional, and Lim, Darren W-T., additional

Published
2021
Full Text
View/download PDF

23. Abstract CT150: Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)

Author

Lim, Darren Wan-Teck, primary, Wang, Hung-Ming, additional, Li, Shau-Hsuan, additional, Ngan, Roger, additional, Dechaphunkul, Arunee, additional, Zhang, Li, additional, Yen, Chia Jui, additional, Chan, Po Chung, additional, Chakrabandhu, Somvilai, additional, Ma, Brigette, additional, Tanasanvimon, Suebpong, additional, Lee, Victor, additional, Lou, Pei-Jen, additional, Li, Zujun, additional, Spira, Alexander, additional, Sukari, Ammar, additional, Guigay, Joël, additional, McCune, Steven, additional, Sun, Yongjian, additional, Szpakowski, Sebastian, additional, Yao, Yao, additional, Fan, Xueqiang, additional, Manenti, Luigi, additional, and Even, Caroline, additional

Published
2019
Full Text
View/download PDF

24. Abstract CT022: Evaluation of oral microbiome profiling as a response biomarker in squamous cell carcinoma of the head and neck: Analyses from CheckMate 141

Author

Ferris, Robert L., primary, Blumenschein, George, additional, Harrington, Kevin, additional, Fayette, Jérôme, additional, Guigay, Joël, additional, Colevas, A. Dimitrios, additional, Licitra, Lisa, additional, Vokes, Everett, additional, Gillison, Maura, additional, Even, Caroline, additional, Ho, Cheryl, additional, Tahara, Makoto, additional, Haddad, Robert, additional, Lynch, Mark, additional, Monga, Manish, additional, Bandyopadhyay, Somnath, additional, Jabado, Omar, additional, and Kao, Henry, additional

Published
2017
Full Text
View/download PDF

25. Abstract CT021: Tumor-associated immune cell PD-L1 expression and peripheral immune profiling: Analyses from CheckMate 141

Author

Ferris, Robert L., primary, Blumenschein, George, additional, Harrington, Kevin, additional, Fayette, Jérôme, additional, Guigay, Joël, additional, Colevas, A. Dimitrios, additional, Licitra, Lisa, additional, Kasper, Stefan, additional, Even, Caroline, additional, Worden, Francis, additional, Saba, Nabil F., additional, Vokes, Everett, additional, Ho, Cheryl, additional, Concha-Benavente, Fernando, additional, Greenawalt, Danielle, additional, Jin, Chelsea, additional, Lynch, Mark, additional, Tahara, Makoto, additional, Haddad, Robert, additional, Monga, Manish, additional, Kao, Henry, additional, and Gillison, Maura, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results